膝关节腔注射氨甲环酸对单纯半月板损伤患者关节肿胀、疼痛、关节功能恢复的影响(4)
[ 8 ] CID J， LOZANO M. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty： results of a meta-analysis of randomized controlled trials[J]. Transfusion，2005，45(8)：1302-1307.
[ 9 ] HO KM， ISMAIL H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty： a meta-analysis[J]. Anaesth Intensi Care，2003，31(5)：529-537.
[10] ZOHAR E， ELLIS M， IFRACH N， et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement[J]. Anesth Analg， 2004，99(6)：1679-1683.
[11] SIMPSON LA， BARRETT JP JR. Factors associated with poor results following arthroscopic subcutaneous lateral retinacular release[J]. Clin Orthop Relat Res，1984(186)：165-171.
[12] DUNN CJ， GOA KL. Tranexamic acid： a review of its use in surgery and other indications[J]. Drugs，1999，57(6)：1005-1032.
[13] ZUFFEREY P， MERQUIOL F， LAPORTE S， et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedicb surgery？[J]. Anesthesiology， 2006，105(5)：1034-1046.
[14] 中華医学会骨科分会.中国骨科大手术静脉血栓栓塞症预防指南[J]. 中华骨科杂志， 2016， 36(2)： 65-71.
[15] WU Q，ZHANG HA，LIU SL，et al. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty？ A meta-analysis of 34 randomized controlled trials[J]. Eur J Orthop Surg Traumatol，2015， 25(3)：525-541.
[16] POERAN J， RASUL R， SUZUKI S， et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or kneearthroplasty in the United States： retrospective analysis of effectiveness and safety[J]. BMJ，2014. DOI： 10.1136/bmj.g4829.
(收稿日期：2017-07-10 修回日期：2018-03-02)
(编辑：陈 宏), 百拇医药(李明晋 陈小华 唐晓莉 李凑 梁婷 王海若 曾凤玲 王霁 刘曦)
[ 9 ] HO KM， ISMAIL H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty： a meta-analysis[J]. Anaesth Intensi Care，2003，31(5)：529-537.
[10] ZOHAR E， ELLIS M， IFRACH N， et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement[J]. Anesth Analg， 2004，99(6)：1679-1683.
[11] SIMPSON LA， BARRETT JP JR. Factors associated with poor results following arthroscopic subcutaneous lateral retinacular release[J]. Clin Orthop Relat Res，1984(186)：165-171.
[12] DUNN CJ， GOA KL. Tranexamic acid： a review of its use in surgery and other indications[J]. Drugs，1999，57(6)：1005-1032.
[13] ZUFFEREY P， MERQUIOL F， LAPORTE S， et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedicb surgery？[J]. Anesthesiology， 2006，105(5)：1034-1046.
[14] 中華医学会骨科分会.中国骨科大手术静脉血栓栓塞症预防指南[J]. 中华骨科杂志， 2016， 36(2)： 65-71.
[15] WU Q，ZHANG HA，LIU SL，et al. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty？ A meta-analysis of 34 randomized controlled trials[J]. Eur J Orthop Surg Traumatol，2015， 25(3)：525-541.
[16] POERAN J， RASUL R， SUZUKI S， et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or kneearthroplasty in the United States： retrospective analysis of effectiveness and safety[J]. BMJ，2014. DOI： 10.1136/bmj.g4829.
(收稿日期：2017-07-10 修回日期：2018-03-02)
(编辑：陈 宏), 百拇医药(李明晋 陈小华 唐晓莉 李凑 梁婷 王海若 曾凤玲 王霁 刘曦)